Pre-order Enquiry
Request Free Sample
Global Clinical Immunoanalyzer Market Growth 2019-2024
SKU ID : LPI-13842401 | Publishing Date : 07-Feb-2019 | No. of pages : 162
Clinical Immunoanalyzer detect and quantify specific analytes in blood or in samples of body fluids by utilizing immunoassay methodologies such as immunoprecipitation, particle immunoassays, immunonephelometry, radioimmunoassay, enzyme immunoassay, fluorescent immunoassay, and chemiluminescent immunoassays.
The global average price of clinical immunoanalyzer is in the decrease trend, from 19.36 K USD/Unit in 2012 to 19.19 K USD/Unit in 2016.
The classification of Clinical immunoanalyzer includes CLIA, ELISA, RIA, FIA and Other, and the proportion of CLIA in 2016 is about 46%, and the proportion is in increasing trend from 2012 to 2016.
Clinical immunoanalyzer is widely used in Hospital, Clinic and Other Institutions. The most proportion of clinical immunoanalyzer is used in Hospital, and the consumption proportion is about 72%.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 27%.
Market competition is intense. Roche Diagnostics, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Clinical Immunoanalyzer market will register a 5.6% CAGR in terms of revenue, the global market size will reach US$ 5200 million by 2024, from US$ 3740 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Clinical Immunoanalyzer business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Immunoanalyzer market by product type, application, key manufacturers and key regions and countries.
This study considers the Clinical Immunoanalyzer value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
CLIA
ELISA
RIA
FIA
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche Diagnostics
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
Bio-Rad
BioMerieux
DiaSorin
Werfen Life
Thermo Fisher Scientific
Tosoh Corporation
Randox Laboratories
Snibe
Transasia
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Clinical Immunoanalyzer consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Clinical Immunoanalyzer market by identifying its various subsegments.
Focuses on the key global Clinical Immunoanalyzer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clinical Immunoanalyzer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Clinical Immunoanalyzer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The global average price of clinical immunoanalyzer is in the decrease trend, from 19.36 K USD/Unit in 2012 to 19.19 K USD/Unit in 2016.
The classification of Clinical immunoanalyzer includes CLIA, ELISA, RIA, FIA and Other, and the proportion of CLIA in 2016 is about 46%, and the proportion is in increasing trend from 2012 to 2016.
Clinical immunoanalyzer is widely used in Hospital, Clinic and Other Institutions. The most proportion of clinical immunoanalyzer is used in Hospital, and the consumption proportion is about 72%.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 27%.
Market competition is intense. Roche Diagnostics, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Clinical Immunoanalyzer market will register a 5.6% CAGR in terms of revenue, the global market size will reach US$ 5200 million by 2024, from US$ 3740 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Clinical Immunoanalyzer business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Immunoanalyzer market by product type, application, key manufacturers and key regions and countries.
This study considers the Clinical Immunoanalyzer value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
CLIA
ELISA
RIA
FIA
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche Diagnostics
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
Bio-Rad
BioMerieux
DiaSorin
Werfen Life
Thermo Fisher Scientific
Tosoh Corporation
Randox Laboratories
Snibe
Transasia
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Clinical Immunoanalyzer consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Clinical Immunoanalyzer market by identifying its various subsegments.
Focuses on the key global Clinical Immunoanalyzer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clinical Immunoanalyzer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Clinical Immunoanalyzer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
